Brain

Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia

Fast track designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenstrom’s MacroglobulinemiaSAN FRANCISCO, Dec. 19,…

1 year ago

Best Mounjaro Alternative Over the Counter: Cheaper, Safer Alternatives to Tirzepatide OTC

If you are considering a natural over the counter Mounjaro alternative for 2025 - we have the top 3 options…

1 year ago

Lexaria Forms New Scientific Advisory Board

North American drug delivery development experts added to help guide Lexaria's strategic plans KELOWNA, BC / ACCESSWIRE / December 18,…

1 year ago

BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions

Collaboration will leverage BioAge's differentiated human longevity data and platform and Novartis expertise in the biology of physical exercise to…

1 year ago

Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome

Dravet syndrome is a genetic developmental and epileptic encephalopathy (DEE) often caused by a mutation in SCN1A This is the…

1 year ago

Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies

- Improvements Across Measures of Behavior, Function, Cognition and Movement - - Expediting Plans to Advance CT1812 into Late-Stage Trials…

1 year ago

Vandria announces first subjects dosed in its first-in-human Phase 1 clinical trial of VNA-318 brain-penetrant mitophagy inducer

LAUSANNE, Switzerland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Vandria SA, a company at the vanguard of mitochondrial therapeutics developing first-in-class…

1 year ago

ISS National Lab-Sponsored Projects on Cancer, Neurodegenerative Conditions, and More Return From Space Station

Nearly 50 payloads safely splashed down to Earth on SpaceX's 31st Commercial Resupply Services Mission for NASA KENNEDY SPACE CENTER, Fla.,…

1 year ago

CLR Neurosthenics® launches neurophysiological assessment platform to help prevent sports injuries, optimize performance and improve rehabilitation

LOS ANGELES, Dec. 17, 2024 /PRNewswire/ -- Sports and recreational injuries send more than 3.5 million Americans to the hospital…

1 year ago

BRAIN.ONE Brain Fitness Platform Announces Strategic Partnership with Acclaimed Thought Leader Tim Storey and Global Recovery Advocate Darren Prince

ASPEN, Colo., Dec. 17, 2024 /PRNewswire/ -- BRAIN.ONE, a groundbreaking personalized brain fitness platform, is pleased to announce a partnership…

1 year ago